HEADER TRANSFERASE/TRANSFERASE INHIBITOR 13-DEC-19 6V9C TITLE CRYSTAL STRUCTURE OF FGFR4 KINASE DOMAIN IN COMPLEX WITH COVALENT TITLE 2 INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: FIBROBLAST GROWTH FACTOR RECEPTOR 4; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: FGFR-4; COMPND 5 EC: 2.7.10.1; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: FGFR4, JTK2, TKF; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS TYROSINE KINASE INHIBITOR, COVALENT INHIBITOR, FGFR, KINASE, KEYWDS 2 TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.LIU,H.LIU REVDAT 3 11-OCT-23 6V9C 1 REMARK REVDAT 2 04-NOV-20 6V9C 1 JRNL REVDAT 1 25-MAR-20 6V9C 0 JRNL AUTH H.LIU,D.NIU,R.T.THAM SJIN,A.DUBROVSKIY,Z.ZHU,J.J.MCDONALD, JRNL AUTH 2 K.FAHNOE,Z.WANG,M.MUNSON,A.SCHOLTE,M.BARRAGUE,M.FITZGERALD, JRNL AUTH 3 J.LIU,M.KOTHE,F.SUN,J.MURTIE,J.GE,J.ROCNIK,D.HARVEY, JRNL AUTH 4 B.OSPINA,K.PERRON,G.ZHENG,E.SHEHU,L.A.D'AGOSTINO JRNL TITL DISCOVERY OF SELECTIVE, COVALENT FGFR4 INHIBITORS WITH JRNL TITL 2 ANTITUMOR ACTIVITY IN MODELS OF HEPATOCELLULAR CARCINOMA. JRNL REF ACS MED.CHEM.LETT. V. 11 1899 2020 JRNL REFN ISSN 1948-5875 JRNL PMID 33062171 JRNL DOI 10.1021/ACSMEDCHEMLETT.9B00601 REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.7 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 42.02 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 3 NUMBER OF REFLECTIONS : 24186 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.201 REMARK 3 R VALUE (WORKING SET) : 0.199 REMARK 3 FREE R VALUE : 0.227 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.090 REMARK 3 FREE R VALUE TEST SET COUNT : 1231 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 50 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.92 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 81.09 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 484 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.3163 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 461 REMARK 3 BIN R VALUE (WORKING SET) : 0.3143 REMARK 3 BIN FREE R VALUE : 0.3535 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.75 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 23 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2210 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 45 REMARK 3 SOLVENT ATOMS : 165 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 32.17 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 37.40 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.09890 REMARK 3 B22 (A**2) : -0.52590 REMARK 3 B33 (A**2) : 0.62470 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -1.18700 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.240 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.157 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.137 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.154 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.136 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.949 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.919 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2310 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 3133 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 792 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : 378 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2310 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 279 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 2752 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 0.96 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.13 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 15.92 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|453 - A|801 } REMARK 3 ORIGIN FOR THE GROUP (A): 12.5204 3.9380 13.1305 REMARK 3 T TENSOR REMARK 3 T11: 0.0599 T22: 0.0477 REMARK 3 T33: 0.0504 T12: -0.0592 REMARK 3 T13: -0.0305 T23: 0.0254 REMARK 3 L TENSOR REMARK 3 L11: 0.5235 L22: 1.0159 REMARK 3 L33: 1.4389 L12: -0.5356 REMARK 3 L13: 0.5046 L23: -0.3452 REMARK 3 S TENSOR REMARK 3 S11: -0.0481 S12: 0.1297 S13: 0.0657 REMARK 3 S21: -0.0022 S22: -0.0475 S23: -0.0459 REMARK 3 S31: -0.0009 S32: 0.0525 S33: 0.0956 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6V9C COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 16-DEC-19. REMARK 100 THE DEPOSITION ID IS D_1000245866. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-JUN-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : OXFORD SAPPHIRE CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 24253 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : 42.020 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.6 REMARK 200 DATA REDUNDANCY : 3.300 REMARK 200 R MERGE (I) : 0.04900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.94 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.99 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.56000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 3OXZ REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.45 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.30 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM BIS-TRIS PH 5.5, 14% (W/V) REMARK 280 POLYETHYLENE GLYCOL 3,350, 200 MM LITHIUM SULFATE AND 2% (W/V) REMARK 280 GLYCEROL, BATCH MODE, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 29.33500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 449 REMARK 465 VAL A 450 REMARK 465 SER A 451 REMARK 465 LEU A 452 REMARK 465 GLY A 476 REMARK 465 CYS A 477 REMARK 465 PHE A 478 REMARK 465 GLY A 578 REMARK 465 SER A 579 REMARK 465 ALA A 634 REMARK 465 ARG A 635 REMARK 465 GLY A 636 REMARK 465 VAL A 637 REMARK 465 HIS A 638 REMARK 465 HIS A 639 REMARK 465 HIS A 752 REMARK 465 HIS A 753 REMARK 465 HIS A 754 REMARK 465 HIS A 755 REMARK 465 HIS A 756 REMARK 465 HIS A 757 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 611 -8.41 80.61 REMARK 500 ASP A 612 47.61 -152.80 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue QS7 A 801 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 802 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 803 DBREF 6V9C A 450 751 UNP P22455 FGFR4_HUMAN 450 751 SEQADV 6V9C MET A 449 UNP P22455 INITIATING METHIONINE SEQADV 6V9C A UNP P22455 PRO 570 DELETION SEQADV 6V9C A UNP P22455 ASP 571 DELETION SEQADV 6V9C A UNP P22455 LEU 572 DELETION SEQADV 6V9C A UNP P22455 SER 573 DELETION SEQADV 6V9C A UNP P22455 PRO 574 DELETION SEQADV 6V9C A UNP P22455 ASP 575 DELETION SEQADV 6V9C A UNP P22455 GLY 576 DELETION SEQADV 6V9C A UNP P22455 PRO 577 DELETION SEQADV 6V9C A UNP P22455 ARG 578 DELETION SEQADV 6V9C HIS A 752 UNP P22455 EXPRESSION TAG SEQADV 6V9C HIS A 753 UNP P22455 EXPRESSION TAG SEQADV 6V9C HIS A 754 UNP P22455 EXPRESSION TAG SEQADV 6V9C HIS A 755 UNP P22455 EXPRESSION TAG SEQADV 6V9C HIS A 756 UNP P22455 EXPRESSION TAG SEQADV 6V9C HIS A 757 UNP P22455 EXPRESSION TAG SEQRES 1 A 300 MET VAL SER LEU ASP LEU PRO LEU ASP PRO LEU TRP GLU SEQRES 2 A 300 PHE PRO ARG ASP ARG LEU VAL LEU GLY LYS PRO LEU GLY SEQRES 3 A 300 GLU GLY CYS PHE GLY GLN VAL VAL ARG ALA GLU ALA PHE SEQRES 4 A 300 GLY MET ASP PRO ALA ARG PRO ASP GLN ALA SER THR VAL SEQRES 5 A 300 ALA VAL LYS MET LEU LYS ASP ASN ALA SER ASP LYS ASP SEQRES 6 A 300 LEU ALA ASP LEU VAL SER GLU MET GLU VAL MET LYS LEU SEQRES 7 A 300 ILE GLY ARG HIS LYS ASN ILE ILE ASN LEU LEU GLY VAL SEQRES 8 A 300 CYS THR GLN GLU GLY PRO LEU TYR VAL ILE VAL GLU CYS SEQRES 9 A 300 ALA ALA LYS GLY ASN LEU ARG GLU PHE LEU ARG ALA ARG SEQRES 10 A 300 ARG PRO PRO GLY SER SER GLU GLY PRO LEU SER PHE PRO SEQRES 11 A 300 VAL LEU VAL SER CYS ALA TYR GLN VAL ALA ARG GLY MET SEQRES 12 A 300 GLN TYR LEU GLU SER ARG LYS CYS ILE HIS ARG ASP LEU SEQRES 13 A 300 ALA ALA ARG ASN VAL LEU VAL THR GLU ASP ASN VAL MET SEQRES 14 A 300 LYS ILE ALA ASP PHE GLY LEU ALA ARG GLY VAL HIS HIS SEQRES 15 A 300 ILE ASP TYR TYR LYS LYS THR SER ASN GLY ARG LEU PRO SEQRES 16 A 300 VAL LYS TRP MET ALA PRO GLU ALA LEU PHE ASP ARG VAL SEQRES 17 A 300 TYR THR HIS GLN SER ASP VAL TRP SER PHE GLY ILE LEU SEQRES 18 A 300 LEU TRP GLU ILE PHE THR LEU GLY GLY SER PRO TYR PRO SEQRES 19 A 300 GLY ILE PRO VAL GLU GLU LEU PHE SER LEU LEU ARG GLU SEQRES 20 A 300 GLY HIS ARG MET ASP ARG PRO PRO HIS CYS PRO PRO GLU SEQRES 21 A 300 LEU TYR GLY LEU MET ARG GLU CYS TRP HIS ALA ALA PRO SEQRES 22 A 300 SER GLN ARG PRO THR PHE LYS GLN LEU VAL GLU ALA LEU SEQRES 23 A 300 ASP LYS VAL LEU LEU ALA VAL SER HIS HIS HIS HIS HIS SEQRES 24 A 300 HIS HET QS7 A 801 35 HET SO4 A 802 5 HET SO4 A 803 5 HETNAM QS7 N-[(3R,4S)-4-{[6-(2,6-DICHLORO-3,5-DIMETHOXYPHENYL)-8- HETNAM 2 QS7 METHYL-7-OXO-7,8-DIHYDROPYRIDO[2,3-D]PYRIMIDIN-2- HETNAM 3 QS7 YL]AMINO}OXOLAN-3-YL]PROP-2-ENAMIDE HETNAM SO4 SULFATE ION FORMUL 2 QS7 C23 H23 CL2 N5 O5 FORMUL 3 SO4 2(O4 S 2-) FORMUL 5 HOH *165(H2 O) HELIX 1 AA1 PRO A 463 ASP A 465 5 3 HELIX 2 AA2 SER A 510 GLY A 528 1 19 HELIX 3 AA3 ASN A 557 ARG A 565 1 9 HELIX 4 AA4 SER A 585 ARG A 606 1 22 HELIX 5 AA5 ALA A 614 ARG A 616 5 3 HELIX 6 AA6 LEU A 651 MET A 656 5 6 HELIX 7 AA7 ALA A 657 ARG A 664 1 8 HELIX 8 AA8 THR A 667 THR A 684 1 18 HELIX 9 AA9 PRO A 694 GLY A 705 1 12 HELIX 10 AB1 PRO A 715 TRP A 726 1 12 HELIX 11 AB2 ALA A 729 ARG A 733 5 5 HELIX 12 AB3 THR A 735 SER A 751 1 17 SHEET 1 AA1 5 LEU A 467 GLY A 474 0 SHEET 2 AA1 5 GLN A 480 PHE A 487 -1 O VAL A 481 N LEU A 473 SHEET 3 AA1 5 ALA A 497 MET A 504 -1 O VAL A 502 N VAL A 482 SHEET 4 AA1 5 TYR A 547 GLU A 551 -1 O VAL A 550 N ALA A 501 SHEET 5 AA1 5 LEU A 536 CYS A 540 -1 N LEU A 537 O ILE A 549 SHEET 1 AA2 2 VAL A 618 VAL A 620 0 SHEET 2 AA2 2 MET A 626 ILE A 628 -1 O LYS A 627 N LEU A 619 LINK SG CYS A 552 CBG QS7 A 801 1555 1555 1.86 SITE 1 AC1 14 LEU A 473 VAL A 481 ARG A 483 LYS A 503 SITE 2 AC1 14 GLU A 520 VAL A 550 GLU A 551 CYS A 552 SITE 3 AC1 14 ALA A 553 GLY A 556 LEU A 619 ALA A 629 SITE 4 AC1 14 ASP A 630 HOH A 947 SITE 1 AC2 7 ARG A 559 ARG A 616 THR A 646 SER A 647 SITE 2 AC2 7 ASN A 648 ARG A 650 HOH A 979 SITE 1 AC3 3 HIS A 727 ALA A 728 HOH A 932 CRYST1 44.067 58.670 60.747 90.00 97.57 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.022693 0.000000 0.003016 0.00000 SCALE2 0.000000 0.017044 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016606 0.00000